Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae
about
Extended-spectrum beta-lactamases: a clinical updatePlasmid-determined AmpC-type beta-lactamases.Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniaeExtended-spectrum beta-lactamases in Klebsiella pneumoniae bloodstream isolates from seven countries: dominance and widespread prevalence of SHV- and CTX-M-type beta-lactamasesEpidemiology of Carbapenem Resistant Klebsiella pneumoniae Infections in Mediterranean CountriesMolecular basis of bacterial outer membrane permeability revisitedNavigating Microbiological Food Safety in the Era of Whole-Genome SequencingComparative proteomics of inner membrane fraction from carbapenem-resistant Acinetobacter baumannii with a reference strainContribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniaeCefepime vs other antibacterial agents for the treatment of Enterobacter species bacteremia.Efficacy of cefepime and imipenem in experimental murine pneumonia caused by porin-deficient Klebsiella pneumoniae producing CMY-2 beta-Lactamase.Prevalence of AmpC and other beta-lactamases in enterobacteria at a large urban university hospital in Brazil.Rapid identification of carbapenemase genes in gram-negative bacteria with an oligonucleotide microarray-based assayOccurrence and detection of AmpC beta-lactamases among Escherichia coli, Klebsiella pneumoniae, and Proteus mirabilis isolates at a veterans medical center.Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum beta-lactamase detection methods.Characterization of the extended-spectrum beta-lactamase reference strain, Klebsiella pneumoniae K6 (ATCC 700603), which produces the novel enzyme SHV-18Diversity of SHV and TEM beta-lactamases in Klebsiella pneumoniae: gene evolution in Northern Taiwan and two novel beta-lactamases, SHV-25 and SHV-26.Cefepime, piperacillin-tazobactam, and the inoculum effect in tests with extended-spectrum beta-lactamase-producing Enterobacteriaceae.Evaluation of beta-lactamase inhibitors in disk tests for detection of plasmid-mediated AmpC beta-lactamases in well-characterized clinical strains of Klebsiella sppOccurrence of extended-spectrum beta-lactamases in members of the family Enterobacteriaceae in Italy: implications for resistance to beta-lactams and other antimicrobial drugsDown-regulation of porin M35 in Moraxella catarrhalis by aminopenicillins and environmental factors and its potential contribution to the mechanism of resistance to aminopenicillinsImplication of porins in beta-lactam resistance of Providencia stuartii.Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.Functional characterization of a novel outer membrane porin KpnO, regulated by PhoBR two-component system in Klebsiella pneumoniae NTUH-K2044.Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A beta-lactamase, KPC-3, in a New York Medical Center.Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence.Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae.Susceptibility of extended-spectrum-beta-lactamase-producing Enterobacteriaceae according to the new CLSI breakpoints.Rapid induction of high-level carbapenem resistance in heteroresistant KPC-producing Klebsiella pneumoniae.Role of AcrR and ramA in fluoroquinolone resistance in clinical Klebsiella pneumoniae isolates from Singapore.Prevalence of OmpK35 and OmpK36 porin expression in beta-lactamase and non-betalactamase- producing Klebsiella pneumoniae.Carbapenemase-producing Enterobacteriaceae.Role of Klebsiella pneumoniae OmpK35 porin in antimicrobial resistance.Stepwise evolution of pandrug-resistance in Klebsiella pneumoniae.Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010.Antibiotic trapping by plasmid-encoded CMY-2 β-lactamase combined with reduced outer membrane permeability as a mechanism of carbapenem resistance in Escherichia coli.The role of carbapenems in initial therapy for serious Gram-negative infections.AmpC beta-lactamases.Epidemiology and clinical features of bloodstream infections caused by AmpC-type-beta-lactamase-producing Klebsiella pneumoniae.Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development.
P2860
Q24534999-76239A81-72B9-436C-A7AF-D66A21766ACEQ24535748-9440E095-41D9-4D8C-B5B2-09630ABAE5D9Q24550605-10FFE756-1106-4B72-AA25-63D3760D2D02Q24650618-15225902-FC55-4ACA-A967-232CB4E1A308Q26738606-3E2F2CF3-7EBD-48D1-9D0D-3CE4BC5B7AE8Q29616208-09E9EC5A-A84C-4CE1-B6B5-A2A43443B7B2Q30248315-DC7BDF6E-D7AA-44AF-AE4B-0ABB6AD34221Q31071263-4A025B36-558D-4879-B3F2-411E498B3966Q33474709-F8DAC4F4-34F3-481A-A14C-0022902108CEQ33598276-C4952992-7BB4-4CC7-9823-EB584C3B51CBQ33938172-F6093679-B0A5-4A19-9BF6-FDF48C8E9120Q33949179-F841D13E-D476-4CAB-8509-3B8BA15575C0Q33960560-9B18ADDF-A9D1-4577-B2C7-D2D6F70E4049Q33966850-A564C577-A1A4-4960-BDEA-BA2B1FD55D37Q33973139-ED512A6A-09EE-4E6B-A53E-DED93F2B938AQ33980456-E017096C-B7D6-4AC7-85E7-4C0996076372Q33982839-AF0F1615-DFFF-4ADF-9E4B-0F10DFB5F579Q33983667-ACB08899-D8D4-4721-A192-5FBA5FD79859Q34041616-5B9375C4-46C4-47E6-8369-1F63BD593827Q34104453-BAC4C175-8EFF-4DB6-8C99-7996B8929FD8Q34138479-8E07A5D4-6D1D-46CF-8E2A-AEC21A44B02FQ34186495-D74BC558-F500-40F3-97C2-EC1B60EA4961Q34230437-3CD263A0-FAEB-4A82-BD94-D8FEC3361BECQ34358548-C2AD1DA8-04C7-4E65-A19E-AF4F1C6C1F65Q34370760-AF440DE3-DAD0-4E70-A95F-C1AE7364DBD4Q34737663-93B66F13-2019-41E0-9AD0-8F992E4DA35BQ35005872-8B02A203-DA93-4615-A0FB-EEE89C989A1CQ35192249-3D77DBE9-DEE5-4E9F-B1EC-DAD3A5AC1D2BQ35607909-F8410A6A-6F6E-43A1-AB06-0F3FCC9C04A0Q35685143-84AEF678-7BDA-4F7A-8869-F1E286F27CCBQ35699344-1389D31A-708A-4C31-8665-57079EF23866Q35751615-CD0F7E02-AD21-48E7-A897-E75E91A8C62AQ36047378-98240C80-A01E-44A4-932E-46914FDDCDAEQ36174574-49D0F56E-53D2-482B-AEBF-4CB915E57859Q36402271-2E200E48-005A-4E2D-B71B-8D04E51593C3Q37036659-1BB80974-46B3-4598-A769-5927FCB112DBQ37169849-1C568313-54C2-49A3-84C0-B986F5CCDAA9Q37366249-BFD677C3-6ABE-4E07-88CE-EC16A1ADB588Q37568924-5A1EF488-0E63-47FD-B160-5A233AE2A512Q38471723-D928B958-AAC2-42E7-BB76-CC47C9B5DDAF
P2860
Roles of beta-lactamases and porins in activities of carbapenems and cephalosporins against Klebsiella pneumoniae
description
1999 nî lūn-bûn
@nan
1999 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年学术文章
@wuu
1999年学术文章
@zh-cn
1999年学术文章
@zh-hans
1999年学术文章
@zh-my
1999年学术文章
@zh-sg
1999年學術文章
@yue
name
Roles of beta-lactamases and p ...... against Klebsiella pneumoniae
@ast
Roles of beta-lactamases and p ...... against Klebsiella pneumoniae
@en
type
label
Roles of beta-lactamases and p ...... against Klebsiella pneumoniae
@ast
Roles of beta-lactamases and p ...... against Klebsiella pneumoniae
@en
prefLabel
Roles of beta-lactamases and p ...... against Klebsiella pneumoniae
@ast
Roles of beta-lactamases and p ...... against Klebsiella pneumoniae
@en
P2093
P2860
P356
P1476
Roles of beta-lactamases and p ...... against Klebsiella pneumoniae
@en
P2093
A I Suárez
D Alvarez-Díaz
G A Jacoby
S Hernández-Allés
V J Benedí
P2860
P304
P356
10.1128/AAC.43.7.1669
P407
P577
1999-07-01T00:00:00Z